We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BMS’s Opdivo Clinical Trial Shows Promise

News   Apr 19, 2016

 
BMS’s Opdivo Clinical Trial Shows Promise
 
 
Advertisement
 

RELATED ARTICLES

SARS-CoV-2 Spike Protein Structurally Characterized – Along With Its Relative

News

Researchers at the Francis Crick Institute have characterized the structure of the SARS-CoV-2 spike protein as well as its most similar relative in a bat coronavirus. The structures provide clues about how the spike evolved and could help inform vaccine design.

READ MORE

Broader Immune Repertoire for Neonates Exposed to Commensal Bacteria Antigens

News

Fresh evidence shows that early exposure to vaccine-, bacterial- or microbiota-derived antigens has a dramatic effect on the diversity of antibodies an adult mammal will have to fight future infections by pathogens.

READ MORE

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE